Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 5 August 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
In addition to interim results progressing well ahead of the initial assumptions, capital investment related to advanced semiconductors and data centers in the Industrial Automation Business exceeded previous assumptions, driven by AI demand. In the Healthcare Business, further sales expansion is expected through a solid operating environment, the rollout of new products, and strengthened promotional measures. The expected operating environments for the Data Solutions Business and Social Systems Business are unchanged from the previous assumptions.
Impairment loss of ¥17,497 million associated with the classification of assets held for sale and liabilities associated with assets held for sale
| Item | Details |
|---|---|
| Net Sales | 8,800 Hundreds of millions of yen → 9,200 Hundreds of millions of yen（+4.5%） |
| Operating profit | 800 Hundreds of millions of yen → 880 Hundreds of millions of yen（+10.0%） |
| Profit attributable to owners of the parent | 405 Hundreds of millions of yen → 430 Hundreds of millions of yen（+6.2%） |
| Net income per share | Not disclosed → 218.68 yen/sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 5 August 2026 |
| Previous-period results | Fiscal year ending March 2026: revenue ¥768.1 billion, operating profit ¥56.4 billion, profit before tax ¥53.8 billion, profit attributable to owners of the parent ¥22.2 billion |
| Reason for the revision | In addition to interim results progressing well ahead of the initial assumptions, capital investment related to advanced semiconductors and data centers in the Industrial Automation Business exceeded previous assumptions, driven by AI demand. In the Healthcare Business, further sales expansion is expected through a solid operating environment, the rollout of new products, and strengthened promotional measures. The expected operating environments for the Data Solutions Business and Social Systems Business are unchanged from the previous assumptions. |
| Details and amount of extraordinary loss | Impairment loss of ¥17,497 million associated with the classification of assets held for sale and liabilities associated with assets held for sale |
| Dividend forecast revision | The previously undecided interim dividend was set at ¥55 per share, and the year-end dividend forecast was revised to ¥55 per share. The annual dividend forecast remains unchanged at ¥110 per share. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to interim results progressing well ahead of the initial assumptions, capital investment related to advanced semiconductors and data centers in the Industrial Automation Business exceeded previous assumptions, driven by AI demand. In the Healthcare Business, sales are expected to expand on the back of a solid operating environment, the rollout of new products, and strengthened promotional measures. The expected operating environments for the Data Solutions Business and Social Systems Business are unchanged from the previous assumptions.